Cargando…

Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: A systematic review and meta-analysis

BACKGROUND: Summarized data of cardiovascular outcomes trials (CVOTs) of sodium glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have shown a reduction in major adverse cardiovascular event (MACE), whether these benefits are extended in certain ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diallo, Alhassane, Carlos-Bolumbu, Miguel, Galtier, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574412/ https://www.ncbi.nlm.nih.gov/pubmed/36263397 http://dx.doi.org/10.1016/j.eclinm.2022.101697

Ejemplares similares

Larger effect size in composite kidney outcomes than in major cardiovascular events associated with sodium‐glucose cotransporter‐2 (SGLT2) inhibitors compared with glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs): A pooled analysis of type 2 diabetes trials
por: Diallo, Alhassane, et al.
Publicado: (2022)

Efficacy of approved vaccines to prevent COVID-19: a systematic review and network meta-analysis of reconstructed individual patient data from randomized trials
por: Diallo, Alhassane, et al.
Publicado: (2022)

An updated systematic review and network meta-analysis of 25 randomized trials assessing the efficacy and safety of treatments in COVID-19 disease
por: Diallo, Alhassane, et al.
Publicado: (2021)

Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus
por: Raparelli, Valeria, et al.
Publicado: (2020)

Different profiles of body mass index variation among patients with multidrug-resistant tuberculosis: a retrospective cohort study
por: Diallo, Alhassane, et al.
Publicado: (2020)

Shape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin
por: Utzschneider, Kristina M, et al.
Publicado: (2021)

Cardiovascular Disease Protection in Long-Duration Type 1 Diabetes and Sex Differences
por: He, Zhiheng H., et al.
Publicado: (2015)

Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2020)

Glucose lowering does not necessarily reduce cardiovascular risk in type 2 diabetes
por: Bourazana, Angeliki, et al.
Publicado: (2022)

Effect of Obesity Duration and BMI Trajectories on Cardiovascular Disease: A Narrative Review
por: Amani-Beni, Reza, et al.
Publicado: (2023)

Plasma gelsolin levels are associated with diabetes, sex, race, and poverty
por: Noren Hooten, Nicole, et al.
Publicado: (2023)

Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
por: Infante, Marco, et al.
Publicado: (2022)

Correlation of Body Mass Index (BMI) with Saliva and Blood Glucose Levels in Diabetic and Non-Diabetic Patients
por: Patel, Bhumika J, et al.
Publicado: (2023)

BMI variability and incident diabetes mellitus, Tehran Lipid and Glucose Study (TLGS)
por: Mehran, Ladan, et al.
Publicado: (2022)

Response to: Concerns regarding the reliability of subgroup effects
por: Diallo, Alhassane
Publicado: (2023)

Sex and race define the effects of adverse childhood experiences on self-reported BMI and metabolic health biomarkers
por: Leachman, Jacqueline R., et al.
Publicado: (2022)

Association Between Cardiovascular Disease Risk Factors and Mortality in Adults With Diabetes: A Stratified Analysis by Sex, Race, and Ethnicity
por: Savage, Kristina, et al.
Publicado: (2022)

Rigiscan Evaluation of Men with Diabetes Mellitus and Erectile Dysfunction and Correlation with Diabetes Duration, Age, BMI, Lipids and HbA1c
por: Andersson, Daniel Peter, et al.
Publicado: (2015)

Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes
por: den Ouden, Henk, et al.
Publicado: (2016)

UTILIZATION TRENDS OF NEWLY APPROVED GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES
por: Dave, Chintan, et al.
Publicado: (2019)

Progression of glucose‐lowering diabetes therapy in TECOS
por: Bethel, M. Angelyn, et al.
Publicado: (2018)

Use of Glucose-Lowering Agents in Diabetes and CKD
por: Alicic, Radica Z., et al.
Publicado: (2022)

Induction of remission in diabetes by lowering blood glucose
por: Weir, Gordon C., et al.
Publicado: (2023)

Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
por: Reaven, Peter D., et al.
Publicado: (2009)

Patterns of Racing and Career Duration of Racing Greyhounds in New Zealand
por: Palmer, Anna L., et al.
Publicado: (2020)

Sex-specific associations between adolescent categories of BMI with cardiovascular and non-cardiovascular mortality in midlife
por: Furer, Ariel, et al.
Publicado: (2018)

Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics
por: Youk, Tae Mi, et al.
Publicado: (2020)

Latent Constructs in Psychosocial Factors Associated with Cardiovascular Disease: An Examination by Race and Sex
por: Clark, Cari Jo, et al.
Publicado: (2012)

Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes
por: Nyström, Thomas, et al.
Publicado: (2017)

BMI and Diabetes Risk in Singaporean Chinese
por: Odegaard, Andrew O., et al.
Publicado: (2009)

Sex differences in the non-linear association between BMI and LDL cholesterol in type 2 diabetes
por: Li, Kun, et al.
Publicado: (2023)

Association of short sleep duration with impaired glucose tolerance or diabetes mellitus
por: Katano, Sayuri, et al.
Publicado: (2011)

TV Viewing and BMI by Race/Ethnicity and Socio-Economic Status
por: Shuval, Kerem, et al.
Publicado: (2013)

Concurrent partnerships in Cape Town, South Africa: race and sex differences in prevalence and duration of overlap
por: Beauclair, Roxanne, et al.
Publicado: (2015)

Disparities in sleep duration among American children: effects of race and ethnicity, income, age, and sex
por: Giddens, Natasha T., et al.
Publicado: (2022)

From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes
por: Mosenzon, Ofri, et al.
Publicado: (2021)

Sex differences in prognostic role of fasting glucose, Oral glucose tolerance, and HbA1c in diabetic cardiovascular disease
por: Yoshida, Yilin, et al.
Publicado: (2023)

Impact of Lowering BMI Cut Points as Recommended in the Revised American Diabetes Association's Standards of Medical Care in Diabetes—2015 on Diabetes Screening in Asian Americans
por: Hsia, Daniel S., et al.
Publicado: (2015)

Changes in BMI, Duration of Overweight and Obesity, and Glucose Metabolism: 45 Years of Follow-up of a Birth Cohort
por: Power, Chris, et al.
Publicado: (2011)

Examination of the Association between Insufficient Sleep and Cardiovascular Disease and Diabetes by Race/Ethnicity
por: Vishnu, Abhishek, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fih0atdngvqihgegae8n8s2m4v